Found: 16
Select item for more details and to access through your institution.
AQP4-IgG autoimmunity in Japan and Germany: Differences in clinical profiles and prognosis in seropositive neuromyelitis optica spectrum disorders.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2021, p. 1, doi. 10.1177/20552173211006862
- By:
- Publication type:
- Article
AQP4-IgG autoimmunity in Japan and Germany: Differences in clinical profiles and prognosis in seropositive neuromyelitis optica spectrum disorders.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2021, v. 7, n. 2, p. 1, doi. 10.1177/20552173211006862
- By:
- Publication type:
- Article
Risk factors for fingolimod-induced lymphopenia in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2018, v. 4, n. 2, p. 1, doi. 10.1177/2055217318759692
- By:
- Publication type:
- Article
Risk factors for fingolimod-induced lymphopenia in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2018, v. 4, n. 1, p. 1, doi. 10.1177/2055217318759692
- By:
- Publication type:
- Article
Elevated serum levels of bone morphogenetic protein-9 are associated with better outcome in AQP4-IgG seropositive NMOSD.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-30594-z
- By:
- Publication type:
- Article
Serum anti-John Cunningham virus antibody seroprevalence and index among Japanese patients with neuromyelitis optica spectrum disorders.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: Their possible role on blood–brain barrier disruption.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 8, p. 1072, doi. 10.1177/1352458516672015
- By:
- Publication type:
- Article
Seronegative neuromyelitis optica spectrum disorder patients diagnosed using new diagnostic criteria.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 10, p. 1371, doi. 10.1177/1352458515615954
- By:
- Publication type:
- Article
Imeglimin‐mediated glycemic control in maternally inherited deafness and diabetes.
- Published in:
- Journal of Diabetes Investigation, 2023, v. 14, n. 12, p. 1419, doi. 10.1111/jdi.14085
- By:
- Publication type:
- Article
Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis.
- Published in:
- PLoS ONE, 2020, v. 15, n. 4, p. 1, doi. 10.1371/journal.pone.0224419
- By:
- Publication type:
- Article
Clinical difference after the first optic neuritis between aquaporin-4-IgG-associated and myelin oligodendrocyte glycoprotein-IgG-associated disorders.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 4, p. 1996, doi. 10.1007/s00415-021-10764-7
- By:
- Publication type:
- Article
Serum anti-JCV antibody indexes in Japanese patients with multiple sclerosis: elevations along with fingolimod treatment duration.
- Published in:
- Journal of Neurology, 2018, v. 265, n. 5, p. 1145, doi. 10.1007/s00415-018-8813-z
- By:
- Publication type:
- Article
Contributions of CSF interleukin-6 elevation to the pathogenesis of myelin oligodendrocyte glycoprotein antibody–associated disease.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 8, p. 977, doi. 10.1177/13524585241254731
- By:
- Publication type:
- Article
Higher longitudinal brain white matter atrophy rate in aquaporin-4 IgG-positive NMOSD compared with healthy controls.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-38893-1
- By:
- Publication type:
- Article
Higher longitudinal brain white matter atrophy rate in aquaporin-4 IgG-positive NMOSD compared with healthy controls.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-38893-1
- By:
- Publication type:
- Article
Comparison of cognitive and brain grey matter volume profiles between multiple sclerosis and neuromyelitis optica spectrum disorder.
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0184012
- By:
- Publication type:
- Article